Cynata Therapeutics Limited (ASX:CYP)
0.340
-0.015 (-4.23%)
Mar 6, 2026, 4:10 PM AEST
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of 80.73 million as of March 6, 2026. Its market cap has increased by 48.88% in one year.
Market Cap
80.73M
Enterprise Value
78.15M
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
Market Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has increased from 15.60M to 80.73M, an increase of 417.67%. That is a compound annual growth rate of 9.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 81.80M |
| Alterity Therapeutics | 76.13M |
| Imugene | 75.56M |
| Radiopharm Theranostics | 74.43M |
| Arovella Therapeutics | 94.16M |
| Prescient Therapeutics | 63.09M |
| Paradigm Biopharmaceuticals | 112.01M |
| Neurizon Therapeutics | 57.16M |